Axsome reported strong fourth-quarter sales Tuesday, but AXSM stock tumbled on a setback for the company's Alzheimer's agitation treatment.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Axsome Tumbles On An Unexpected Setback For Its Alzheimer’s Drug